Question 7 Flashcards
Beta Blockers
- reduce heart rate and cardiac output
- suppress renin activity
- reduce SNS system activity
Beta Blockers MOA
Bind adrenergic receptors to prevent their activation. They also inhibit the sympathetic nervous system.
2 categories of Beta Blockers
- Selective- bind beta 1 receptors
2. Non-selective- bind both beta 1 and 2 receptors
Beta Blocker Recommendations
- prescribed to patients with stage c/NYHA class 1-4 HFrEF upon diagnosis.
- initiated at low doses
- long term treatment should be maintained and avoid abrupt withdrawal
- patient has history or current fluid retention, diuretics should be prescribed as well.
Angiotensin Converting Enzyme Inhibitors (ACEis)
MOA & Examples
- suppresses the Raas system by blocking the formation of angiotensin II.
- this decreases vasoconstriction and the secretion of aldosterone.
- ex: enalapril
ACEis Recommendations
- initiates at low doses and increases as tolerated.
- They’ve shown to reduce the risk of death and hospitalizations in patients w/ stage C/NYHA class 1-4 HFrEF
- ACEis have lower effects on BP in black patients.
Angiotensin II Receptor Blocker (ARBs)
Decrease vasoconstriction and reabsorption of salt/water, which leads to decreased bp.
ARB MOA and Example
- Block vasoconstrictor and aldosterone secreting effects of ang 2 by selectively blocking binding of ang 2 to AT1 receptor in tissues
- Ex: valsartan
ARB Recommendations
- start at a low dose and titrate up
- recommended for patients w/ stage c/ NYHA class 1-4 HFrEF who are
- intolerant to ACE b/c of cough or angioedema
- already taking ARB for another condition
Diuretics
- inhibit the reabsorption of sodium in renal tubules.
- this increases diuresis leading to reduced blood volume
Different types of diuretics
loop
thiazide
potassium
Diuretics recommendations
- can be added on to an ACE/ARB/BB
- recommended for patients w/fluid retention and fall in stage c/NYHA class 1-4 HFrEF